-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Upgrades Generation Bio to Outperform, Lowers Price Target to $5.5

Benzinga·12/16/2025 13:54:09
语音播报
Wedbush analyst David Nierengarten upgrades Generation Bio (NASDAQ:GBIO) from Neutral to Outperform and lowers the price target from $7 to $5.5.